BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2005
View Archived Issues
MF-101: a safer alternative for hormonal therapy
Read More
In vivo studies confirm the anti-HSV activity of a cream formulation of resveratrol
Read More
Anti-HBV activity of ellagic acid
Read More
Vestipitant shows anxiolytic-like profile in rodent and primate behavioral models
Read More
DPI-221 shows potential as an agent for overactive bladder and urinary incontinence
Read More
Scientists describe advantages of using two antibodies in PAGRIT
Read More
Aripiprazole reported effective in preventing relapse of patients with bipolar disorder
Read More
Scientists find link between novel locus and left main coronary artery disease risk
Read More
Phase II study discontinued for vicriviroc in treatment-naive HIV patients
Read More
Cellegy completes enrollment in phase III HIV prevention study of Savvy
Read More
Approval of muraglitazar may require new trials
Read More
Enrollment begins in phase I Chemophase study
Read More
Biolex to create commercial line for Kringle's NK4 protein
Read More
Update on ongoing Avian flu research
Read More
Positive phase III results for GSK drug from Flamel collaboration
Read More
Dacogen under review in U.S. and Europe for MDS
Read More
Positive phase I findings for Fentanyl Taifun
Read More
Chromos Molecular Systems to acquire Targeted Molecules
Read More
Accelerated approval for Arranon
Read More
FDA extends Exubera review period
Read More
Erbitux sBLA accepted for filing, granted priority review
Read More
Cerepro MAA accepted for review
Read More
Schering-Plough seeks Japanese approval of Temodal
Read More
Escitalopram reported to improve kleptomania, PMDD and depression
Read More
MD-1100 demonstrates gastrointestinal activity in healthy volunteers
Read More
Novel antiinfective agents emerge from sanofi-aventis R&D
Read More
New therapeutic agents claimed for metabolic disorders
Read More